ibrutinib,rituximab
abbvie,janssen
[' ibru', 'lymphoma']
triangle study - ffs - ai&gt; a (soc)
i is not inferior to soc (including auto) practice changing : ibrutinib should be added to upfront rchop/dhap. do we still need auto - longer follow up needed to answer this question #jesc2022 ash22 
Hematology/BMT Attending @UKMarkey  Area of interest include acute leukemias, allogeneic stem cell transplantation and GvHD